AC
TTOO

Aisling Capital’s T2 Biosystems, Inc TTOO Stock Holding History

Aisling Capital’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-305
Closed -$4.89M – 14
2017
Q2 		$4.89M Sell
305
-261
-46% -$5.23M 0.84% 12
2017
Q1 		$14.9M Hold
566
– – 2.71% 8
2016
Q4 		$14.9M Hold
566
– – 3.46% 8
2016
Q3 		$20.5M Hold
566
– – 4.22% 10
2016
Q2 		$22.3M Hold
566
– – 5.28% 6
2016
Q1 		$27.9M Hold
566
– – 5.59% 7
2015
Q4 		$31M Buy
566
+61
+12% +$3.29M 5.34% 6
2015
Q3 		$22.1M Hold
505
– – 3.89% 10
2015
Q2 		$41M Hold
505
– – 6.1% 6
2015
Q1 		$39.2M Hold
505
– – 5.12% 6
2014
Q4 		$48.5M Hold
505
– – 7.36% 6
2014
Q3 		$45.6M Buy
+505
New +$47M 8.85% 3

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Aisling Capital's TTOO Position: Q3 2017 in Review

Aisling Capital sold out of T2 Biosystems, Inc (TTOO) in Q3 2017, closing a stake of 305 shares — an estimated $4.89M sold.

Aisling Capital first reported a position in TTOO in Q3 2014 and held it in 12 quarters. The position peaked at $48.5M in Q4 2014. 36 funds tracked by Wall St. Rank hold TTOO as of Q3 2017.

  • Aisling Capital reported no remaining T2 Biosystems, Inc position as of Q3 2017 after selling out during the quarter.
  • Aisling Capital sold 305 T2 Biosystems, Inc shares in Q3 2017, an estimated $4.89M.
  • Aisling Capital first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 12 quarters.
  • Aisling Capital's T2 Biosystems, Inc position peaked at $48.5M in Q4 2014.
  • 36 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2017.

Based on Aisling Capital's 13F filing for Q3 2017, filed 9 Nov 2017.